PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
We are a property Market Place matching Buyers and Sellers, Landlords and Tenants without the use of estate agents. The online portal will dramatically reduce the fees that sellers and landlords pay agents to find buyers and tenants for their properties
days to go:
Expired
investment:
Withheld
SL'M is the world's first zero sugar, zero carb, zero fat range of wines which is approved by both the TSO and FSA. During COVID-19, the company witnessed record earnings, amidst profitable online sales in March 2020. The company has also been featured in publications such as Cosmopolitan, The Sun, and many more. Slim Wine's audience comprises Gen X, Millennials, and Boomers, giving the company a great cross-generational position in the market. The company has served over 2 million glasses of wine and generated profits of over £1 million amidst a growing customer base. Slim Wine's latest vintage, Cuvée 450, was showcased at the 'Royal Berkshire Polo Club'. The company will use the investment to boost sales and marketing, advertising campaigns, and wine production.
days to go:
Expired
investment:
£262,948
Notes is a well-established coffee shop and wine bar concept with nine locations in central London. They pride themselves in being able to source and roast at their own roastery in Canning Town which provides over 1.4m cups of coffee a year. By serving high volumes of their single-origin speciality coffee, Notes have doubled their revenue to almost £5m by just opening shops in four locations since 2015.
days to go:
Expired
investment:
£1,194,330
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
Creating grand design homes in a factory that are high-tech, spacious and environmentally friendly. nHouse's modernised construction process means that less time can be spent building a home which has resulted in an increased production output and therefore greater efficiency. A nHouse modular home can be constructed within 12 to 16 weeks and they have already received more than 500 sales enquiries. The company has also attained BOPAS accreditation from the Council of Mortgage Lenders to reassure home insurers and mortgage providers.
days to go:
Expired
investment:
£307,170
Doodle Drinks (DD) aims to make all-natural soft drinks that kids can enjoy. The company cites research data arguing that children aged 18 months to 18 years are drinking 26% fewer sugary drinks and consumption for 10-year olds has fallen 35%. It wants to capture this sentiment and deliver a soft drink that's a healthy choice for both parents and their kids. DD has secured distribution with the noted distributor, Bravura Foods. It has also signed a partnership with the largest independent bottler of beverages in Europe and North America, Refresco, who have over 60 manufacturing sites globally to fulfil its objective. DD will use the investment to grow its business, execute its marketing strategy and increase its product range.
days to go:
Expired
investment:
£877,830
